녹십자웰빙
234690KOSDAQ의약품 제조업56.5 / 100
Reference Date: 2026-04-13
Company InformationBased on 2025 Annual Report
Business Overview
LS Wellbeing operates in professional pharmaceuticals, clinic-based health functional foods, and medical devices/cosmetics (aesthetics), achieving a 6.1% revenue growth to 127.9 billion KRW in 2024. Key products include injectable nutritional solutions like Lainex Injection, health functional food brand Dr.PNT, and medical devices such as HA fillers and skin boosters, with active exports to the Chinese market.
Number of Employees
330people
Average Salary
71.5M KRW
Score Calculation Basis
Detailed Financial Score
1.6x industry avg (risky)
2.0x industry avg (risky)
2.1x industry avg (excellent)
2.6x industry avg (risky)
Avg ▲17.0% (2-year basis)
Avg ▲28.7% (2-year basis)
Avg ROE 7.7% (improving, 3yr)
Detailed News Sentiment
- PositiveGC녹십자웰빙 스킨부스터 ‘지셀르 리본느’ 국내 출시
GC녹십자웰빙이 인체조직 기반 ECM 스킨부스터 '지셀르 리본느'를 국내 출시하며 메디컬 에스테틱 플랫폼 전환을 본격화했습니다.
- PositiveGC녹십자웰빙, '지셀르 리본느' 출시…메디컬 에스테틱 확장
GC녹십자웰빙이 자체 에스테틱 통합 브랜드 '지셀르'의 첫 제품인 '지셀르 리본느'를 출시하며 메디컬 에스테틱 사업을 확장합니다.
Detailed Momentum
52w upper range (76%)
1m +43.61% (strong rise)
Volume decreasing
Detailed Disclosure
- Neutral주식등의대량보유상황보고서(일반)2026-04-09
- Neutral주식등의대량보유상황보고서(일반)2026-04-07
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-07
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-07
- Neutral주식등의대량보유상황보고서(일반)2026-04-07
